Q4 2018 Holdings
Filed 2019-02-14 | 83 holdings | $31.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.1K | 148,617 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $2.2K | 540,637 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.6K | 42,800 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.6K | 332,511 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $2.7K | 27,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.9K | 808,000 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $3.0K | 80,000 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.1K | $4,000,000 | 0.0% |
| Luminex Corp | COM | 55027E102 | $3.2K | 138,391 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $3.5K | 463,228 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $3.7K | 93,942 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.8K | 41,609 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.9K | 55,008 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $4.1K | 396,013 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.1K | 34,000 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $4.3K | 272,474 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $5.0K | 92,691 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $5.1K | 141,770 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $5.2K | 143,764 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.3K | 64,900 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $8.9K | 312,119 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $10.0K | 104,306 | 0.0% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $14.8K | 13,680,554 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $25.4K | 181,675 | 0.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $415.0K | 50,000 | 1.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $846.0K | 472,859 | 2.7% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $946.0K | 246,900 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.2M | 185,826 | 3.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.7M | 464,415 | 11.9% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $4.0M | 715,538 | 12.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $4.8M | 77,242 | 15.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.6M | 58,300 | 17.8% |
| Atricure Inc(ATRC) | COM | 04963C209 | $9.8M | 318,729 | 31.0% |